BioSpring GmbH
Uwe Leitermann is a finance professional with extensive experience in management and controlling across various sectors. Since 2020, Uwe has served as the Head of Finance and Controlling and Prokurist at BioSpring GmbH. Prior to this role, Uwe held the position of Kaufmännischer Leiter at MHK Group AG from 2019 to 2020 and was the Kaufmännischer Geschäftsführer at mainzplus CITYMARKETING GmbH between 2013 and 2018. Uwe began the career at Commerzbank AG as a Controller from 2008 to 2012. Uwe earned a Bachelor of Arts in Wirtschaftswissenschaften from RheinMain University of Applied Sciences, graduating in 2007.
This person is not in any teams
This person is not in any offices
BioSpring GmbH
BioSpring is a leading industry expert in oligonucleotide science and technology, specializing in high-quality cGMP manufacturing and analytics for commercial programs and clinical phases I-III, in addition to preclinical material supply and diagnostic manufacturing. We are a privately owned company of ~600 employees committed to providing expert support through all phases and regulatory filings, including highly flexible and customizable solutions to accelerate therapeutic programs through the entire drug development lifecycle. Headquartered in the center of Europe, in Frankfurt, Germany, we are an international company with a subsidiary in the United States and a local presence in Japan. Our global clients can rely on our quality and expertise, guided by our passion for innovation and more than 27 years of experience. Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology – making great strides and breakthroughs possible. We are driven by our desire for a healthier world. Restoring hope in patients living with debilitating diseases is our daily motivation to progress novel nucleic acid-based therapies to their commercial promise. Privacy notice: https://www.biospring.de/datenschutz-socialmedia/